Inacio MCS, Paxton EW, Graves SE, Namba RS, Nemes S. Projected increase in total knee arthroplasty in the United States - an alternative projection model. Osteoarthritis Cartilage. 2017; Nov;25(11):1797–803.
Article
CAS
PubMed
Google Scholar
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; Apr;89(4):780–5.
PubMed
Google Scholar
Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman S, Figgie MP, Mandl LA. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991-2005. J Rheumatol. 2014; May;41(5):867–74.
Article
PubMed
Google Scholar
Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman SM, Figgie MP, Mandl LA. US trends in rates of arthroplasty for inflammatory arthritis including rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis. Arthritis Rheumatol. 2014; Jun;66(6):1432–9.
Article
PubMed
Google Scholar
Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann Rheum Dis. 2007; Mar;66(3):341–4.
Article
PubMed
Google Scholar
Nikiphorou E, Carpenter L, Morris S, Macgregor AJ, Dixey J, Kiely P, et al. Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts. Arthritis Rheumatol. 2014; May;66(5):1081–9.
Article
PubMed
Google Scholar
Aaltonen KJ, Virkki LM, Jamsen E, Sokka T, Konttinen YT, Peltomaa R, et al. Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study. Semin Arthritis Rheum. 2013; Aug;43(1):55–62.
Article
CAS
PubMed
Google Scholar
Strand V, Sharp V, Koenig AS, Park G, Shi Y, Wang B, et al. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis. 2012; Jul;71(7):1143–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shah UH, Mandl LA, Mertelsmann-Voss C, Lee YY, Alexiades MM, Figgie MP, et al. Systemic lupus erythematosus is not a risk factor for poor outcomes after total hip and total knee arthroplasty. Lupus. 2015; Jan 16;24(9):900–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goodman SM, Johnson B, Zhang M, Huang WT, Zhu R, Figgie M, et al. Patients with Rheumatoid Arthritis have Similar Excellent Outcomes after Total Knee Replacement Compared with Patients with Osteoarthritis. J Rheumatol. 2016; Jan;43(1):46–53.
Article
PubMed
Google Scholar
Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014; Feb;66(2):254–63.
Article
PubMed
Google Scholar
Ravi B, Croxford R, Hollands S, Paterson MJ, Bogoch E, Kreder H, et al. Patients with rheumatoid arthritis are at increased risk for complications following total joint arthroplasty. Arthritis Rheum. 2013; Nov 19;66(2):254–63.
Article
Google Scholar
Singh JA, Inacio MC, Namba RS, Paxton EW. Rheumatoid arthritis is associated with higher 90-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort study. Arthritis Care Res (Hoboken). 2014; Oct 9;67(5):718–24.
Article
Google Scholar
Lin JA, Liao CC, Lee YJ, Wu CH, Huang WQ, Chen TL. Adverse outcomes after major surgery in patients with systemic lupus erythematosus: a nationwide population-based study. Ann Rheum Dis. 2014; Sep;73(9):1646–51.
Article
PubMed
Google Scholar
Salt E, Wiggins AT, Rayens MK, Morris BJ, Mannino D, Hoellein A, et al. Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis. Semin Arthritis Rheum. 2017; Feb;46(4):423–9.
Article
CAS
PubMed
Google Scholar
Mandl LA, Zhu R, Huang WT, Zhang M, Alexiades MM, Figgie MP, et al. Short Term Total Hip Arthroplasty Outcomes in Patients with Psoriatic Arthritis, Psoriasis Skin Disease, and Osteoarthritis. Arthritis Rheumatol. 2015; Sep 11;68(2):410–7.
Article
Google Scholar
Goodman SM, Zhu R, Figgie MP, Huang WT, Mandl LA. Short-term total hip replacement outcomes in ankylosing spondylitis. J Clin Rheumatol. 2014; Oct;20(7):363–8.
PubMed
Google Scholar
Singh JA, Inacio MC, Namba RS, Paxton EW. Rheumatoid Arthritis is Associated With Higher Ninety-Day Hospital Readmission Rates Compared to Osteoarthritis After Hip or Knee Arthroplasty: A Cohort Study. Arthritis Care Res (Hoboken). 2015; May;67(5):718–24.
Article
Google Scholar
Yazdanyar A, Wasko MC, Kraemer KL, Ward MM. Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: Comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum. 2012; Aug;64(8):2429–37.
Article
PubMed
PubMed Central
Google Scholar
Yazdanyar A, Wasko MC, Scalzi LV, Kraemer KL, Ward MM. Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012; Dec 4;65(6):986–91.
Article
Google Scholar
Schnaser EA, Browne JA, Padgett DE, Figgie MP, D'Apuzzo MR. Perioperative Complications in Patients With Inflammatory Arthropathy Undergoing Total Hip Arthroplasty. J Arthroplasty. 2016; Oct;31(10):2286–90.
Article
PubMed
Google Scholar
Stern SH, Insall JN, Windsor RE, Inglis AE, Dines DM. Total knee arthroplasty in patients with psoriasis. Clin Orthop Relat Res. 1989;248(248):108–10. discussion 111
Google Scholar
Menon TJ, Wroblewski BM. Charnley low-friction arthroplasty in patients with psoriasis. Clin Orthop Relat Res. 1983; Jun;176(176):127–8.
Google Scholar
Ravi B, Croxford R, Austin PC, Hollands S, Paterson JM, Bogoch E, et al. Increased surgeon experience with rheumatoid arthritis reduces the risk of complications following total joint arthroplasty. Arthritis Rheumatol. 2014; Mar;66(3):488–96.
Article
PubMed
Google Scholar
Mortazavi SM, Molligan J, Austin MS, Purtill JJ, Hozack WJ, Parvizi J. Failure following revision total knee arthroplasty: infection is the major cause. Int Orthop. 2011; Aug;35(8):1157–64.
Article
PubMed
Google Scholar
Le DH, Goodman SB, Maloney WJ, Huddleston JI. Current modes of failure in TKA: infection, instability, and stiffness predominate. Clin Orthop Relat Res. 2014; Jul;472(7):2197–200.
Article
PubMed
PubMed Central
Google Scholar
Thiele K, Perka C, Matziolis G, Mayr HO, Sostheim M, Hube R. Current failure mechanisms after knee arthroplasty have changed: polyethylene wear is less common in revision surgery. J Bone Joint Surg Am. 2015; May 6;97(9):715–20.
Article
PubMed
Google Scholar
Jamsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am. 2009; Jan;91(1):38–47.
Article
PubMed
Google Scholar
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD, INFORM Team. Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. PLoS One. 2016; Mar 3;11(3):e0150866.
Article
PubMed
PubMed Central
Google Scholar
Singh JA, Cameron C, Noorbaloochi S, Cullis T, Tucker M, Christensen R, et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015; May 11;386(9990):258–65.
Article
PubMed
PubMed Central
Google Scholar
Shah UH, Mandl LA, Mertelsmann-Voss C, Lee YY, Alexiades MM, Figgie MP, et al. Systemic lupus erythematosus is not a risk factor for poor outcomes after total hip and total knee arthroplasty. Lupus. 2015; Aug;24(9):900–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
ZJ LV, Mandl LA, Johnson BK, Figgie MP, Boettner F, Lee YY, et al. Rheumatoid Arthritis Does Not Increase Risk of Short-term Adverse Events after Total Knee Arthroplasty: A Retrospective Case-control Study. J Rheumatol. 2015; May 1;42(7):1123–30.
Article
Google Scholar
Johnson BK, Goodman SM, Alexiades MM, Figgie MP, Demmer RT, Mandl LA. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J Rheumatol. 2013; May;40(5):617–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
George MD, Baker JF, Yenchih Hsu J, Wu Q, Xie F, Chen L, et al. Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty. Arthritis Care Res (Hoboken). 2017; Jan 27;69(12):1845–54.
Article
CAS
Google Scholar
Goodman SM, Menon I, Christos PJ, Smethurst R, Bykerk VP. Management of perioperative tumour necrosis factor alpha inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis. Rheumatology (Oxford). 2016; Mar;55(3):573–82.
Google Scholar
Ruyssen-Witrand A, Gossec L, Salliot C, Luc M, Duclos M, Guignard S, et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol. 2007; May-Jun;25(3):430–6.
CAS
PubMed
Google Scholar
Weaver A, Troum O, Hooper M, Koenig AS, Chaudhari S, Feng J, et al. Rheumatoid arthritis disease activity and disability affect the risk of serious infection events in RADIUS 1. J Rheumatol. 2013; Aug;40(8):1275–81.
Article
PubMed
Google Scholar
Somayaji R, Barnabe C, Martin L. Risk factors for infection following total joint arthroplasty in rheumatoid arthritis. Open Rheumatol J. 2013; Nov 29;7:119–24.
Article
PubMed
PubMed Central
Google Scholar
Harpaz R, Ortega-Sanchez I, Seward J. Prevention of Herpes Zoster: Recommendation of the Advisory Committee on Immunization Practices. MMWR. Morbidity and Mortality Weekly Report. 2008;57(05):1–30.
Google Scholar
Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001; Mar;60(3):214–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2017; Jun 16;69(8):1111–24.
Article
Google Scholar
Goodman SM, Miller AS, Turgunbaev M, Guyatt G, Yates A, Springer B, et al. Clinical Practice Guidelines: Incorporating Input From a Patient Panel. Arthritis Care Res (Hoboken). 2017; Jun 16;69(8):1125–30.
Article
Google Scholar
Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006; Feb 21;144(4):249–56.
Article
PubMed
Google Scholar
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; Dec 18;349(25):2399–406.
Article
CAS
PubMed
Google Scholar
Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis. 2011; Jun;70(6):929–34.
Article
PubMed
Google Scholar
van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis. 2009; Sep;68(9):1395–400.
Article
CAS
PubMed
Google Scholar
Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008; Dec 15;59(12):1690–7.
Article
PubMed
Google Scholar
Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; Feb;52(2):402–11.
Article
PubMed
Google Scholar
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005; Mar;52(3):722–32.
Article
PubMed
Google Scholar
Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010; Nov;69(11):1920–5.
Article
PubMed
PubMed Central
Google Scholar
Alemao E, Cawston H, Bourhis F, Al M, Rutten-van Molken M, Liao KP, et al. Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2017; May 1;56(5):777–86.
Google Scholar
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006; Aug;54(8):2550–7.
Article
CAS
PubMed
Google Scholar
Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, et al. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol. 2014; Apr;41(4):680–7.
Article
PubMed
PubMed Central
Google Scholar
Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997; Mar 1;145(5):408–15.
Article
CAS
PubMed
Google Scholar
Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum. 2013; Aug;43(1):77–95.
Article
PubMed
Google Scholar
Fernandez-Nebro A, Rua-Figueroa I, Lopez-Longo FJ, Galindo-Izquierdo M, Calvo-Alen J, Olive-Marques A, et al. Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry. Medicine (Baltimore). 2015; Jul;94(29):e1183.
Article
Google Scholar
Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001; Oct;44(10):2331–7.
Article
CAS
PubMed
Google Scholar
Karp I, Abrahamowicz M, Fortin PR, Pilote L, Neville C, Pineau CA, et al. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum. 2008; Feb 15;59(2):169–75.
Article
CAS
PubMed
Google Scholar
Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, et al. Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Res Ther. 2017; Jul 3;19(1):153. 017-1358-1
Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006; Nov;(11):33, 2167–2172.
Haque N, Lories RJ, de Vlam K. Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study. J Rheumatol. 2016; Feb;43(2):376–82.
Article
CAS
PubMed
Google Scholar
Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015; Feb;74(2):326–32.
Article
PubMed
Google Scholar
Urban MK, Jules-Elysee K, Loughlin C, Kelsey W, Flynn E. The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J. 2008; Feb;4(1):76–80.
Article
CAS
PubMed
Google Scholar
Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011; Aug 15;13(4):R131.
Article
PubMed
PubMed Central
Google Scholar
Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum. 2004; Dec;34(3):585–92.
Article
PubMed
Google Scholar
Domsic RT, Lingala B, Krishnan E. Systemic lupus erythematosus, rheumatoid arthritis, and postarthroplasty mortality: a cross-sectional analysis from the nationwide inpatient sample. J Rheumatol. 2010; Jul;37(7):1467–72.
Article
PubMed
Google Scholar
Babazade R, Yilmaz HO, Leung SM, Zimmerman NM, Turan A. Systemic Lupus Erythematosus Is Associated With Increased Adverse Postoperative Renal Outcomes and Mortality: A Historical Cohort Study Using Administrative Health Data. Anesth Analg. 2017; Apr;124(4):1118–26.
Article
PubMed
Google Scholar
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015; Feb;22(1):162–215.
Article
PubMed
Google Scholar
Jette M, Sidney K, Blumchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 1990; Aug;13(8):555–65.
Article
CAS
PubMed
Google Scholar
Mirfeizi Z, Poorzand H, Javanbakht A, Khajedaluee M. Relationship Between Systemic Lupus Erythematosus Disease Activity Index Scores and Subclinical Cardiac Problems. Iran Red Crescent Med J. 2016; Jul 17;18(8):e38045.
Article
PubMed
PubMed Central
Google Scholar
Divard G, Abbas R, Chenevier-Gobeaux C, Chanson N, Escoubet B, Chauveheid MP, et al. High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study. Arthritis Res Ther. 2017; Jun 13;19(1):132,017–1352-7.
Article
Google Scholar
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation. 2011; Mar 22;123(11):1243–62.
Article
PubMed
PubMed Central
Google Scholar
Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017; Jan;76(1):17–28.
Article
CAS
PubMed
Google Scholar
Crowson CS, Gabriel SE, Semb AG, van Riel PL, Karpouzas G, Dessein PH, et al. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology (Oxford). 2017; Mar 8;56(7):1102–10.
Article
Google Scholar
Arts EE, Popa CD, Den Broeder AA, Donders R, Sandoo A, Toms T, et al. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis. 2016; Apr;75(4):674–80.
Article
CAS
PubMed
Google Scholar
Semb AG, Ikdahl E, Hisdal J, Olsen IC, Rollefstad S. Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases. Int J Cardiol. 2016; Nov 15;223:331–6.
Article
CAS
PubMed
Google Scholar
Johannesdottir SA, Schmidt M, Horvath-Puho E, Sorensen HT. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost. 2012; May;10(5):815–21.
Article
CAS
PubMed
Google Scholar
Kim SC, Schneeweiss S, Liu J, Solomon DH. Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013; Oct;65(10):1600–7.
Google Scholar
Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012; Jan 21;379(9812):244–9.
Article
PubMed
Google Scholar
Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011; Jan 10;9(1):7015-9-1.
Article
Google Scholar
Yusuf HR, Hooper WC, Beckman MG, Zhang QC, Tsai J, Ortel TL. Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases. J Thromb Thrombolysis. 2014; Oct;38(3):306–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie. 2010; Jan;30(1):5,6, 8–9.
Google Scholar
Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum. 2012; Jan;64(1):53–61.
Article
PubMed
PubMed Central
Google Scholar
Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis. 2013; Jul;72(7):1182–7.
Article
PubMed
Google Scholar
Matta F, Singala R, Yaekoub AY, Najjar R, Stein PD. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost. 2009; Jan;101(1):134–8.
CAS
PubMed
Google Scholar
Sun Z, Hesler BD, Makarova N, Dalton JE, Doan M, Moraska A, et al. The Association Between Rheumatoid Arthritis and Adverse Postoperative Outcomes: A Retrospective Analysis. Anesth Analg. 2016; Jun;122(6):1887–93.
Article
PubMed
Google Scholar
Wei J, Li W, Pei Y, Shen Y, Li J. Clinical analysis of preoperative risk factors for the incidence of deep venous thromboembolism in patients undergoing posterior lumbar interbody fusion. J Orthop Surg Res. 2016; Jun 13;11(1):68,016–0403-0.
Article
Google Scholar
Cancienne JM, Werner BC, Browne JA. Complications of Primary Total Knee Arthroplasty Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Osteoarthritis. J Am Acad Orthop Surg. 2016; Aug;24(8):567–74.
Article
PubMed
Google Scholar
Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum. 2005; Sep;(9):52, 2774–2782.
Calvo-Alen J, Toloza SM, Fernandez M, Bastian HM, Fessler BJ, Roseman JM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum. 2005; Jul;52(7):2060–8.
Article
CAS
PubMed
Google Scholar
Habe K, Wada H, Matsumoto T, Ohishi K, Ikejiri M, Matsubara K, et al. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. Intern Med. 2016;55(6):589–95.
Article
CAS
PubMed
Google Scholar
Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010; Feb;8(2):237–42.
Article
CAS
PubMed
Google Scholar
Sciascia S, Cuadrado MJ, Sanna G, Murru V, Roccatello D, Khamashta MA, et al. Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort. Arthritis Care Res (Hoboken). 2014; Dec;66(12):1915–20.
Article
Google Scholar
Reynaud Q, Lega JC, Mismetti P, Chapelle C, Wahl D, Cathebras P, et al. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2014; Jun;13(6):595–608.
Article
CAS
PubMed
Google Scholar
Saunders KH, Erkan D, Lockshin MD. Perioperative management of antiphospholipid antibody-positive patients. Curr Rheumatol Rep. 2014; Jul;16(7):426. 014-0426-7
Raso S, Sciascia S, Kuzenko A, Castagno I, Marozio L, Bertero MT. Bridging therapy in antiphospholipid syndrome and antiphospholipid antibodies carriers: case series and review of the literature. Autoimmun Rev. 2015; Jan;14(1):36–42.
Article
CAS
PubMed
Google Scholar
Cohen H, Hunt BJ, Efthymiou M, Arachchillage DR, Mackie IJ, Clawson S, et al. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial. Lancet Haematol. 2016; Sep;3(9):e426–36.
Article
PubMed
PubMed Central
Google Scholar
Cervera R. CAPS Registry Project Group. Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’. Lupus. 2010; Apr;19(4):412–8.
Article
CAS
PubMed
Google Scholar